WO2025115040 - NOVEL CO-CRYSTALS OF SAROGLITAZAR AND SAROGLITAZAR MG SALT

National phase entry is expected:
Publication Number WO/2025/115040
Publication Date 05.06.2025
International Application No. PCT/IN2024/052314
International Filing Date 30.11.2024
Title [English] NOVEL CO-CRYSTALS OF SAROGLITAZAR AND SAROGLITAZAR MG SALT [French] NOUVEAUX CO-CRISTAUX DE SAROGLITAZAR ET DE SEL DE SAROGLITAZAR MG
Applicants ** ZYDUS LIFESCIENCES LIMITED Zydus Corporate Park, Scheme no. 63, Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, Ahmedabad, Gandhinagar, Gujarat, 382481, IN
Inventors ** PINGALI, Harikishore ZYDUS LIFESCIENCES LIMITED, Zydus Corporate Park, Scheme no. 63, Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, Ahmedabad, Gandhinagar, Gujarat, 382481, IN BANERJEE, Kaushik ZYDUS LIFESCIENCES LIMITED, Zydus Corporate Park, Scheme no. 63, Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, Ahmedabad, Gandhinagar, Gujarat, 382481, IN ZAWARE, Pandurang ZYDUS LIFESCIENCES LIMITED, Zydus Corporate Park, Scheme no. 63, Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, Ahmedabad, Gandhinagar, Gujarat, 382481, IN KUMAR, Sanjay Department of Chemistry BITS Pilani, K K Birla Goa Campus Near NH 17B, Zuarinagar, Goa 403 726, IN
Priority Data 202321081836  01.12.2023  IN 202321081837  01.12.2023  IN
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 2334
EPO Filing, Examination 17203
Japan Filing 556
South Korea Filing 611
USA Filing, Examination 15235
MasterCard Visa
Total: 35939
Abstract [English] The present invention relates to co-crystal of Saroglitazar of formula (I) and Saroglitazar magnesium of formula (Ia), processes for the preparation of these novel co-crystal, use thereof and pharmaceutical composition comprising the same. [French] La présente invention concerne un co-cristal de saroglitazar de formule (I) et de saroglitazar magnésium de formule (Ia), des procédés de préparation de ces nouveaux co-cristaux, leur utilisation et une composition pharmaceutique les comprenant.